Global Non Opioid Pain Patch Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Opioids Market: By Drug Class (Naloxone, Buprenorphine, Methadone), By Distribution Channel (Retail Pharmacies, Hospitals, Rehabilitation), By Treatment Centers (Residential Treatment Centers, Outpatient Treatment Centers, Inpatient Treatment Centers), By Route of Administration (Oral, Parental), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Non Opioid Pain Patch Market size is valued at USD 554.13 million in 2021 and is expected to reach USD 1279.02 million by 2028, at a CAGR of 12.68% during the forecast period 2022-2028. Pain is a symptom, generally resulting from any infection, injury disease or disorder. Several people around the world suffer from the different types of pains such as chronic pain, acute pain, lower back pain, neck pain, headache etc. Chronic pain usually last longer and intense. Pain is treated through the various treatments using, drugs, physical therapy and others. Non opioid pain patches are kind of treatment for the pain. Opioid medicine is used by a huge number of people as a pain reliever. According to the United Nations Office on Drugs and Crime’s figures, nearly 26.4 to 36 million persons worldwide abused opioids in 2012. There has been a rise in demand for non-opioid therapies due to an increase in the rate of addiction and severe side effects associated with long-term use of opioid medications. Non-opioid medicines have analgesic, antipyretic, and anti-inflammatory effects. These drugs work by blocking the enzyme cyclooxygenase at the site of injury, which then prevents the generation of prostaglandins, reducing the release of pain mediators in the peripheral nervous system. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Non Opioid Pain Patch Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Non Opioid Pain Patch Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

Non Opioid Pain Patch Market

MARKET SUMMARY
-
12.68%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.68%
  • Largest Market– North-America
  • Fastest Growing Market– Europe

Non Opioid Pain Patch Market

  • The global Non Opioid Pain Patch Market report gives comprehensive outlook on Non Opioid Pain Patch Market across the globe with special emphasis on key regions such as Asia Pacific, North America, Europe, Latin America, and Middle East and Africa.
  • The report on global Non Opioid Pain Patch Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
  • In February 2018, U.S. Food and Drug Administration has approved Sorrentos non opioid pain patch ZTlido for pain

 

key players
  • Acorda Therapeutics (U.S.)
  • GlaxoSmithKline plc (U.K.)
  • Allergan Plc (Republic of Ireland)
  • Pfizer Inc. (U.S.)
  • IBSA Institut Biochimque SA (Switzerland)
Non Opioid Pain Patch Market

DRIVERS AND RESTRAINTS

With the rise in the number of people suffering from pain disorders, there is a greater demand for new ways to pain management. In addition, rising treatment expenses and an increase in the number of people suffering from chronic and acute pain are two important drivers driving market expansion. Furthermore, as people become more aware of the negative consequences of frequent opioid usage, demand for non-opioid medications has increased. Increased R&D to produce non-opioid medications in response to an increase in opioid medication addiction has fueled market expansion. However, negative concerns associated with long-term or excessive use of non-opioid medications, such as liver or kidney damage, may limit market expansion.


North-America got significant share

Non Opioid Pain Patch Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Non Opioid Pain Patch Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Opioids Market Introduction
2.1. Global Opioids Market – Taxonomy
2.2. Global Opioids Market –Definitions
2.2.1. By Drug Class
2.2.2. By Distribution Channel
2.2.3. By Treatment Centers
2.2.4. By Route of Administration
2.2.5. By Region
3. Global Opioids Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Opioids Market Dynamic Factors – Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios – Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Player’s Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
4. Global Opioids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Opioids Market Forecast, By Drug Class, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Naloxone
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Buprenorphine
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Methadone
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Opioids Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. Retail Pharmacies
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Hospitals
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Rehabilitation Centers
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Market Opportunity Analysis Global Opioids Market Forecast, By Treatment Centers, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. Residential Treatment Centers
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Outpatient Treatment Centers
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Inpatient Treatment Centers
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Market Opportunity Analysis Global Opioids Market Forecast, By Route of Administration, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Oral
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Parental
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Global Opioids Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Opioids Market – Opportunity Analysis Index, By Drug Class, Distribution Channel, Treatment Centers, Route of Administration, and Region, 2022 – 2028
10. North America Opioids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.1.1. Naloxone
10.1.2. Buprenorphine
10.1.3. Methadone
10.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Retail Pharmacies
10.2.2. Hospitals
10.2.3. Rehabilitation
10.3. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Residential Treatment Centers
10.3.2. Outpatient Treatment Centers
10.3.3. Inpatient Treatment Centers
10.4. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Oral
10.4.2. Parental
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Opioids Market – Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2022 – 2028
10.7. North America Opioids Market Dynamics – Trends
11. Europe Opioids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Naloxone
11.1.2. Buprenorphine
11.1.3. Methadone
11.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Retail Pharmacies
11.2.2. Hospitals
11.2.3. Rehabilitation
11.3. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Residential Treatment Centers
11.3.2. Outpatient Treatment Centers
11.3.3. Inpatient Treatment Centers
11.4. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Oral
11.4.2. Parental
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Opioids Market – Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2022 – 2028
11.7. Europe Opioids Market Dynamics – Trends
12. Asia-Pacific Opioids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
12.1. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Naloxone
12.1.2. Buprenorphine
12.1.3. Methadone
12.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Retail Pharmacies
12.2.2. Hospitals
12.2.3. Rehabilitation
12.3. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Residential Treatment Centers
12.3.2. Outpatient Treatment Centers
12.3.3. Inpatient Treatment Centers
12.4. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Oral
12.4.2. Parental
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Rest of Asia-Pacific
12.6. Asia-Pacific Opioids Market – Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2022 – 2028
12.7. Asia-Pacific Opioids Market Dynamics – Trends
13. Latin America Opioids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
13.1. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.1.1. Naloxone
13.1.2. Buprenorphine
13.1.3. Methadone
13.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Retail Pharmacies
13.2.2. Hospitals
13.2.3. Rehabilitation
13.3. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Residential Treatment Centers
13.3.2. Outpatient Treatment Centers
13.3.3. Inpatient Treatment Centers
13.4. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Oral
13.4.2. Parental
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Argentina
13.5.3. Rest of Latin America
13.6. Latin America Opioids Market – Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2022 – 2028
13.7. Latin America Opioids Market Dynamics – Trends
14. Middle East and Africa Opioids Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
14.1. Drug Class Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.1.1. Naloxone
14.1.2. Buprenorphine
14.1.3. Methadone
14.2. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Retail Pharmacies
14.2.2. Hospitals
14.2.3. Rehabilitation
14.3. Treatment Centers Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Residential Treatment Centers
14.3.2. Outpatient Treatment Centers
14.3.3. Inpatient Treatment Centers
14.4. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Oral
14.4.2. Parental
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Saudi Arabia
14.5.2. GCC Countries
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Opioids Market – Opportunity Analysis Index, By Drug Class, By Distribution Channel, By Treatment Centers, Route of Administration, and Country, 2022 – 2028
14.7. MEA Opioids Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug Class Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Omeros
15.2.2. Camurus
15.2.3. Orexo
15.2.4. MediciNova
15.2.5. Teva Pharmaceuticals
15.2.6.  Hikma Pharmaceuticals
15.2.7. Reckitt Benckiser Pharmaceuticals, Inc.
15.2.8. Mylan
15.2.9. Dr. Reddy’s Laboratories
15.2.10. Addinex Technologies, Inc.
15.2.11. Indivior
15.2.12. Alkermes
15.2.13. Titan Pharmaceuticals
16. Research Methodology
17. Key Assumptions and Acronyms


Report

Company Profile

  • Omeros
  • Camurus
  • Orexo
  • MediciNova
  • Teva Pharmaceuticals
  • Hikma Pharmaceuticals
  • Reckitt Benckiser Pharmaceuticals, Inc.
  • Mylan
  • Dr. Reddy’s Laboratories
  • Addinex Technologies, Inc.
  • Indivior
  • Alkermes
  • Titan Pharmaceuticals

Report

Ask An Analyst

 

Description

Non Opioid Pain Patch Market size is valued at USD 554.13 million in 2021 and is expected to reach USD 1279.02 million by 2028, at a CAGR of 12.68% during the forecast period 2022-2028. Pain is a symptom, generally resulting from any infection, injury disease or disorder. Several people around the world suffer from the different types of pains such as chronic pain, acute pain, lower back pain, neck pain, headache etc. Chronic pain usually last longer and intense. Pain is treated through the various treatments using, drugs, physical therapy and others. Non opioid pain patches are kind of treatment for the pain. Opioid medicine is used by a huge number of people as a pain reliever. According to the United Nations Office on Drugs and Crime’s figures, nearly 26.4 to 36 million persons worldwide abused opioids in 2012. There has been a rise in demand for non-opioid therapies due to an increase in the rate of addiction and severe side effects associated with long-term use of opioid medications. Non-opioid medicines have analgesic, antipyretic, and anti-inflammatory effects. These drugs work by blocking the enzyme cyclooxygenase at the site of injury, which then prevents the generation of prostaglandins, reducing the release of pain mediators in the peripheral nervous system. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Non Opioid Pain Patch Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Non Opioid Pain Patch Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX